IL218160A0 - Desferrioxamine-metal complexes for the treatment of immune-related disorders - Google Patents

Desferrioxamine-metal complexes for the treatment of immune-related disorders

Info

Publication number
IL218160A0
IL218160A0 IL218160A IL21816012A IL218160A0 IL 218160 A0 IL218160 A0 IL 218160A0 IL 218160 A IL218160 A IL 218160A IL 21816012 A IL21816012 A IL 21816012A IL 218160 A0 IL218160 A0 IL 218160A0
Authority
IL
Israel
Prior art keywords
desferrioxamine
immune
treatment
metal complexes
related disorders
Prior art date
Application number
IL218160A
Other versions
IL218160A (en
Original Assignee
Yissum Res Dev Co
Mordechai Chevion
Eduards Berenshtein
Hadasit Med Res Service
Vladimir Vinokur
Ron Eliashar
Baruch Bulvik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2010/000681 external-priority patent/WO2011021203A2/en
Application filed by Yissum Res Dev Co, Mordechai Chevion, Eduards Berenshtein, Hadasit Med Res Service, Vladimir Vinokur, Ron Eliashar, Baruch Bulvik filed Critical Yissum Res Dev Co
Priority to IL218160A priority Critical patent/IL218160A/en
Publication of IL218160A0 publication Critical patent/IL218160A0/en
Publication of IL218160A publication Critical patent/IL218160A/en

Links

IL218160A 2009-08-19 2012-02-16 Desferrioxamine-metal complexes for the treatment of immune-related disorders IL218160A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL218160A IL218160A (en) 2009-08-19 2012-02-16 Desferrioxamine-metal complexes for the treatment of immune-related disorders

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23506209P 2009-08-19 2009-08-19
US29859610P 2010-01-27 2010-01-27
US34761710P 2010-05-24 2010-05-24
PCT/IL2010/000681 WO2011021203A2 (en) 2009-08-19 2010-08-19 Desferrioxamine-metal complexes for the treatment of immune-related disorders
IL218160A IL218160A (en) 2009-08-19 2012-02-16 Desferrioxamine-metal complexes for the treatment of immune-related disorders

Publications (2)

Publication Number Publication Date
IL218160A0 true IL218160A0 (en) 2012-07-31
IL218160A IL218160A (en) 2017-07-31

Family

ID=46614882

Family Applications (1)

Application Number Title Priority Date Filing Date
IL218160A IL218160A (en) 2009-08-19 2012-02-16 Desferrioxamine-metal complexes for the treatment of immune-related disorders

Country Status (1)

Country Link
IL (1) IL218160A (en)

Also Published As

Publication number Publication date
IL218160A (en) 2017-07-31

Similar Documents

Publication Publication Date Title
IL253293A0 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
HK1166331A1 (en) Use of an anti-tau ps422 antibody for the treatment of brain diseases -tau ps422
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
GB0910003D0 (en) Novel compounds for the treatment of neurodegenerative diseases
IL211857A (en) System for neurological treatment
ZA201107449B (en) Compounds for the treatment of metabolic disorders
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
ZA201107446B (en) Compounds for the treatment of metabolic disorders
ZA201202346B (en) Therapeutic agent for mood disorders
GB0904284D0 (en) Compounds for the treatment of metabolic disorders
EP2405929A4 (en) Treatment methods for autoimmune disorders
IL225896A0 (en) Treatment of mecp2-associated disorders
ZA201305970B (en) Arylosulfonami for the treatment of cns diseases
EP2536436A4 (en) Antimir-451 for the treatment of polycythemias
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
GB0809476D0 (en) Treatment of neurodegenerative disorders
ZA201204391B (en) Compounds for the treatment of neurologic disorders
IL207906A0 (en) Treatment for ocular-related disorders
IL218160A0 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
HU0900722D0 (en) Compounds for the treatment of neurological disorders
GB0904286D0 (en) Compounds for the treatment of metabolic disorders
GB0904289D0 (en) Compounds for the treatment of metabolic disorders
GB0904288D0 (en) Compounds for the treatment of metabolic disorders
GB0904290D0 (en) Compounds for the treatment of metabolic disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed